000 01158 a2200337 4500
005 20250517212200.0
264 0 _c20180424
008 201804s 0 0 eng d
022 _a1536-5964
024 7 _a10.1097/MD.0000000000010431
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Haiqing
245 0 0 _aTerlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
_h[electronic resource]
260 _bMedicine
_cApr 2018
300 _ae0431 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aHepatorenal Syndrome
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aKidney
_xphysiopathology
650 0 4 _aLypressin
_xadverse effects
650 0 4 _aRecurrence
650 0 4 _aTerlipressin
650 0 4 _aTreatment Outcome
650 0 4 _aVasoconstrictor Agents
_xadverse effects
700 1 _aLiu, Aixiang
700 1 _aBo, Wentao
700 1 _aFeng, Xielin
700 1 _aHu, Yong
773 0 _tMedicine
_gvol. 97
_gno. 16
_gp. e0431
856 4 0 _uhttps://doi.org/10.1097/MD.0000000000010431
_zAvailable from publisher's website
999 _c28300323
_d28300323